CPB vs MDLZ
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 24, 2026
CPB
MDLZ
Investment Advisor Scores
MDLZ
Aug 24, 2026AI Analyst Insights
Detailed Metrics Comparison
| Metric | CPB | MDLZ | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 11.4811 | 21.3675 | CPB |
| PEG Ratio | 0.7914 | 1.0622 | CPB |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -4.4% | 4.1% | MDLZ |
| Earnings Growth | 86.4% | 144.9% | MDLZ |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 43.5/100 | 48.0/100 | MDLZ |
| Profit Margin | 6.1% | 8.9% | MDLZ |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
| Implied Volatility | N/A | N/A | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CPB
MarkupPrice above SMA50, rising 50-day trend (3.7% over 20 days), RSI 63
MDLZ
MarkupPrice above SMA50, rising 50-day trend (0.8% over 20 days), RSI 62
Fundamentals Snapshot
| Metric | CPB | MDLZ |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 12.6 | 19.3 |
| Trailing P/E | 11.7 | 23.6 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.0% |
| Gross Margin | 0.3% | 0.3% |
| Operating Margin | 0.1% | 0.2% |
| EPS | 2.04 | 2.73 |
| Dividend Yield | 0.07% | 0.03% |